Cancer News and Research

Latest Cancer News and Research

Finding epigenetic signature appears to predict inflammation risk in serious type of IBD

With an estimated 1.6 million people in the U.S. dealing with inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective.

20 Sep 2018

Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines

Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

20 Sep 2018

Progenitor cells for human bone and cartilage have been identified

Research published today describes for the first time the identification of human skeletal stem cells. The discovery may enable the development of novel therapeutic strategies for diseases that cause skeletal degeneration.

20 Sep 2018

Sesen Bio to present its three-month Phase 3 VISTA Trial data at Global Congress

Sesen Bio, Inc., a late-stage clinical company developing fusion protein therapies for the treatment of cancer, today announced that the company will present its three-month Phase 3 VISTA Trial data during a poster session at the Global Congress on Bladder Cancer 2018.

20 Sep 2018

New program to reduce harmful stress effectively improves mood in cancer patients

This is a story about something rare in health psychology: a treatment that has gone from scientific discovery, through development and testing, to dissemination and successful implementation nationwide.

20 Sep 2018

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.

20 Sep 2018

Survey: 91% of people around the world believe medical research will result in dementia cure

A new survey from Novartis, Amgen and Banner Alzheimer’s Institute, along with Alzheimer’s Disease International, shows that 91% of people from around the world believe medical research will result in a treatment for dementia.

20 Sep 2018

Rice seeds could hold key to preventing HIV infections

As incredible as it sounds, a rice paddy field could one day yield an inexpensive way to prevent HIV.

20 Sep 2018

Mediterranean-style diet appears to reduce stroke risk in women

One of the largest and longest-running efforts to evaluate the potential benefits of the Mediterranean-style diet in lowering risk of stroke found that the diet may be especially protective in women over 40 regardless of menopausal status or hormone replacement therapy, according to new research in the American Heart Association's journal Stroke.

20 Sep 2018

Cell Medica successfully doses first patient with CMD-501 targeting pediatric neuroblastoma

Cell Medica announces the treatment of the first patient world-wide to receive CMD-501, an autologous CAR-NKT therapy targeting pediatric neuroblastoma

20 Sep 2018

New guidance for treatment of bone loss in hematologic stem cell transplant Recipients

Hematopoietic stem cell transplantation is the treatment of choice for many patients with malignant and non-malignant hematological diseases, such as leukemia and multiple myeloma. The success of recent advances in such transplantation techniques and supportive care measures, has led to greater numbers of long-term HSCT survivors.

20 Sep 2018

UK and European research collaborations receive vote of confidence by three major cancer charities

UK and European research collaborations in cancer research have received a vote of confidence by three major cancer charities, with an announcement today of approximately £30 million into six international projects.

20 Sep 2018

Researchers simulate how different breast tissues respond to heat from MRIs

No woman's breast tissue is the same, so MRIs detecting and monitoring cancer shouldn't treat them all the same.

20 Sep 2018

Study finds factors within cell influencing variability in amount of protein produced

You can think of a cell in your body like a miniature factory, creating a final product called proteins, which carry out various tasks and functions.

20 Sep 2018

New study focuses on two-way gene switches controlling gene activity

Led by ICREA research professors at the Centre for Genomic Regulation, Luciano Di Croce and Marc A. Marti-Renom, the study focused on a set of genes with what's known as bivalent promoters - two-way genetic 'control switches' that are poised either to turn on in early development and rapidly drive high levels of gene activity, or to switch off and shut down the gene completely.

20 Sep 2018

Zika virus could become a weapon against brain cancer

Zika virus infection is a dreaded one that can lead to severe brain damage in the unborn babies of mothers who get it.

20 Sep 2018

Arizona EMTs have 39% higher risk for suicide than general public

Arizona emergency medical technicians' risk for suicide is 39-percent higher than the general public, according to a new study conducted by University of Arizona College of Medicine - Phoenix researchers.

19 Sep 2018

UNC scientists reveal new approach to prevent obesity and diabetes

Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet.

19 Sep 2018

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

An analysis of the NRG Oncology clinical trial NRG-GY003 suggests that adding ipilimumab, a monoclonal antibody that targets the protein receptor CTLA-4, to a regimen with the checkpoint inhibitor nivolumab could improve the proportion with tumor response and progression-free survival hazard rates for women with recurrent epithelial ovarian cancer.

19 Sep 2018

Study shows how cellular waste disposal processes also promote inflammation

A study conducted at the University of California has revealed how cells use G-protein-coupled receptors (GPCRs) and their waste disposal systems to mediate inflammation.

19 Sep 2018

Cancer News and Research

Latest Cancer News and Research

Finding epigenetic signature appears to predict inflammation risk in serious type of IBD

Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines

Progenitor cells for human bone and cartilage have been identified

Sesen Bio to present its three-month Phase 3 VISTA Trial data at Global Congress

New program to reduce harmful stress effectively improves mood in cancer patients

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Survey: 91% of people around the world believe medical research will result in dementia cure

Rice seeds could hold key to preventing HIV infections

Mediterranean-style diet appears to reduce stroke risk in women

Cell Medica successfully doses first patient with CMD-501 targeting pediatric neuroblastoma

New guidance for treatment of bone loss in hematologic stem cell transplant Recipients

UK and European research collaborations receive vote of confidence by three major cancer charities

Researchers simulate how different breast tissues respond to heat from MRIs

Study finds factors within cell influencing variability in amount of protein produced

New study focuses on two-way gene switches controlling gene activity

Zika virus could become a weapon against brain cancer

Arizona EMTs have 39% higher risk for suicide than general public

UNC scientists reveal new approach to prevent obesity and diabetes

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

Study shows how cellular waste disposal processes also promote inflammation

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in